Locoregional Therapy for Intact Primary Tumor in De Novo Stage IV Breast Cancer

Affiliations

¹ Atilla Soran, MD, MPH, FNCBC, University of Pittsburgh Magee-Womens Hospital, Pittsburgh, PA; Ozgur Aytac, MD, FEBS, Baskent University, Adana, Turkey; and Serdar Ozbas, MD, FEBS, Private Practice, Ankara, Turkey.

Comment

Atilla Soran et al. J Clin Oncol. 2022.

. 2022 Nov 20;40(33):3897-3898.

doi: 10.1200/JCO.22.00802. Epub 2022 Jul 12.

¹ Atilla Soran, MD, MPH, FNCBC, University of Pittsburgh Magee-Womens Hospital, Pittsburgh, PA; Ozgur Aytac, MD, FEBS, Baskent University, Adana, Turkey; and Serdar Ozbas, MD, FEBS, Private Practice, Ankara, Turkey.

No abstract available

Comment in

Reply to B. Ulaş Kahya et al and A. Soran et al.
Khan SA, Zhao F, Goldstein L, Sparano J, Sledge G. Khan SA, et al. J Clin Oncol. 2022 Nov 20;40(33):3899-3901. doi: 10.1200/JCO.22.00861. Epub 2022 Jul 12. J Clin Oncol. 2022. PMID: 35820109 No abstract available.

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108).
Khan SA, Zhao F, Goldstein LJ, Cella D, Basik M, Golshan M, Julian TB, Pockaj BA, Lee CA, Razaq W, Sparano JA, Babiera GV, Dy IA, Jain S, Silverman P, Fisher CS, Tevaarwerk AJ, Wagner LI, Sledge GW. Khan SA, et al. J Clin Oncol. 2022 Mar 20;40(9):978-987. doi: 10.1200/JCO.21.02006. Epub 2022 Jan 7. J Clin Oncol. 2022. PMID: 34995128 Free PMC article. Clinical Trial.